
|Videos|December 10, 2014
Improving Drug Interaction Alert Content
Daniel C. Malone, RPh, PhD, FAMCP, describes the factors that could improve drug interaction alert content.
Advertisement
Daniel C. Malone, RPh, PhD, FAMCP, a professor of pharmacy at the University of Arizona College of Pharmacy, describes the factors that could improve drug interaction alert content.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
2
FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer
3
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
4
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
5














































































































































































































